Treatment of a case of COVID-19 by intravenous immunoglobulin
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secon...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716520303179 |
_version_ | 1818837334067511296 |
---|---|
author | Mustafa Çolak Serdar Kalemci Aydın Sarıhan |
author_facet | Mustafa Çolak Serdar Kalemci Aydın Sarıhan |
author_sort | Mustafa Çolak |
collection | DOAJ |
description | Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secondary immune deficiencies and autoimmune/inflammatory conditions. IVIG administration could be beneficial in the treatment of patients with severe COVID-19. In this respect, this presentation aimed to report a case of COVID-19 treated with IVIG. |
first_indexed | 2024-12-19T03:20:51Z |
format | Article |
id | doaj.art-986faa059c4f43779aa59e77c3964702 |
institution | Directory Open Access Journal |
issn | 2213-7165 |
language | English |
last_indexed | 2024-12-19T03:20:51Z |
publishDate | 2021-03-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Global Antimicrobial Resistance |
spelling | doaj.art-986faa059c4f43779aa59e77c39647022022-12-21T20:37:46ZengElsevierJournal of Global Antimicrobial Resistance2213-71652021-03-0124106107Treatment of a case of COVID-19 by intravenous immunoglobulinMustafa Çolak0Serdar Kalemci1Aydın Sarıhan2Department of Chest Diseases, Isparta City Hospital, Isparta, TurkeyDepartment of Chest Diseases, Medical Park Gebze Hospital, Kocaeli, TurkeyDepartment of Emergency Medicine, Manisa City Hospital, Manisa, Turkey; Corresponding author.Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secondary immune deficiencies and autoimmune/inflammatory conditions. IVIG administration could be beneficial in the treatment of patients with severe COVID-19. In this respect, this presentation aimed to report a case of COVID-19 treated with IVIG.http://www.sciencedirect.com/science/article/pii/S2213716520303179COVID-19Coronavirusintravenous immunoglobulin |
spellingShingle | Mustafa Çolak Serdar Kalemci Aydın Sarıhan Treatment of a case of COVID-19 by intravenous immunoglobulin Journal of Global Antimicrobial Resistance COVID-19 Coronavirus intravenous immunoglobulin |
title | Treatment of a case of COVID-19 by intravenous immunoglobulin |
title_full | Treatment of a case of COVID-19 by intravenous immunoglobulin |
title_fullStr | Treatment of a case of COVID-19 by intravenous immunoglobulin |
title_full_unstemmed | Treatment of a case of COVID-19 by intravenous immunoglobulin |
title_short | Treatment of a case of COVID-19 by intravenous immunoglobulin |
title_sort | treatment of a case of covid 19 by intravenous immunoglobulin |
topic | COVID-19 Coronavirus intravenous immunoglobulin |
url | http://www.sciencedirect.com/science/article/pii/S2213716520303179 |
work_keys_str_mv | AT mustafacolak treatmentofacaseofcovid19byintravenousimmunoglobulin AT serdarkalemci treatmentofacaseofcovid19byintravenousimmunoglobulin AT aydınsarıhan treatmentofacaseofcovid19byintravenousimmunoglobulin |